| X23-03-ZQ105 |
Galα(1-3) core 6-fucosylated N-glycan, 2-AB label, 500 pmol/vial
|
|
| X23-03-ZQ106 |
Disialyloctasaccharide
|
|
| X23-03-ZQ107 |
Disialylnonasaccharide-β-ethylazide
|
|
| X23-03-ZQ108 |
Globo-H ceramide
|
|
| X23-03-ZQ109 |
Disialylnonasaccharide-β-pNP
|
|
| X23-03-ZQ110 |
Fradiomycin sulfate
|
|
| X23-03-ZQ111 |
Neu5Gcα(2-6) core 6-fucosylated N-glycan, 2-AB label, 500 pmol/vial
|
|
| X23-03-ZQ112 |
MANT-M3GN2-DNP
|
|
| X23-03-ZQ113 |
Sialyl lewis X-lactose
|
|
| X23-03-ZQ114 |
Galα(1-3) N-glycan, 2-AB label, 500 pmol/vial
|
|
| X23-03-ZQ115 |
3-G1F, 2-AB label, 500 pmol/vial
|
|
| X23-03-ZQ116 |
Neu5Gcα(2-6) N-glycan, 2-AB label, 500 pmol/vial
|
|
| X23-03-ZQ117 |
G2-Peptide
|
|
| X23-03-ZQ118 |
G2 Glycan
|
|
| X23-03-ZQ119 |
Gb4 ceramide
|
|
| X23-03-ZQ120 |
Gb5-PrN3
|
|
| X23-03-ZQ121 |
6-G1F, 2-AB label, 500 pmol/vial
|
|
| X23-03-ZQ122 |
Chitopentaose pentahydrochloride
|
|
| X23-03-ZQ123 |
Gb5-β-pNP
|
|
| X23-03-ZQ124 |
SGN
|
|
